We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
1989 Ogura Memorial Lecture: Mediastinal Dissection.
- Authors
Sisson, George A.
- Abstract
As I prepared this talk, I realized what an honor it is for me to have been selected the Joseph H. Ogura lecturer. It gives me double pleasure and comfort to accept. Joe Ogura was a long-time, close friend and an inordinately respected role model. Joe and I shared many stimulating and productive moments, and I was on the receiving end most of the time. He was a true scholar. Early in his career, he initiated basic laryngeal surgeries whereby voice was preserved. These conservation cancer surgeries so stimulated me that I performed six supraglottic operations while still a young upstart in Syracuse, New York. His detailed, well-illustrated descriptions of this innovative work awakened world interest and changed the treatment of laryngeal carcinomas. I worked closely with Dr. Joe for many years, as a founding member of the American Society of Head and Neck Surgery, as a travelling companion for the National Cancer Institute Head and Neck Cancer cadre, and as a confidante, during which time he convinced me to become Department Head at Northwestern Medical School in Chicago. For that, I shall ever be grateful The mediastinal dissection was introduced in 1962 to manage an otherwise uniformly fatal problem in head and neck oncology: stomal recurrence of laryngeal, squamous cell cancer. The morbidity and mortality rates continued to be high and the survival rates low, but they were an improvement over those of other treatment plans. Since then, refinements of the ablative techniques and major advances in the reconstructive techniques have significantly decreased morbidity and mortality rates. The most recent data indicate a 45% survival rate at 42 months. It is evident that early diagnosis and staging of stomal recurrences will yield successful results. Because the mediastinal dissection operation is now safe, it should be applied more liberally in head and neck oncology situations such as subglottic extension of laryngeal cancer, advanced thyroid cancers, cervical esophageal and tracheal cancers, and all head and neck tumors with low-nodal disease.
- Publication
Laryngoscope, 1989, Vol 99, Issue 12, p1262
- ISSN
0023-852X
- Publication type
Article
- DOI
10.1288/00005537-198912000-00010